Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 4Plasma cell 2Other hematologic neoplasm 2Gastrointestinal 2Thoracic 1Myeloid 1Gynecologic 1

Conditions

Vomiting 1Gastrointestinal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Radiation 24Panitumumab 24Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Aprepitant × Gastrointestinal × Clear all
NCT05711823 2024-01-23

Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC

Guangxi Medical University

Phase 3 Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03674294 2023-02-08

CINV

Sun Yat-sen University

Phase 3 Completed
248 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡